Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

86.76 +1.28 (+1.50%)
Streaming Delayed Price Updated: 3:46 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,369,323
Open 84.67
Bid (Size) 86.74 (2)
Ask (Size) 86.78 (14)
Prev. Close 85.48
Today's Range 84.34 - 86.95
52wk Range 57.52 - 132.09
Shares Outstanding 392,100,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants
is it the end of the diabetes industry? Here's a small cap that could upend the business models of pharma giants... 
Via Benzinga
DXCM Q1 Earnings Call: Coverage Expansion and Product Pipeline Shape 2025 Outlook
Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The company expects the full year’s revenue to be... 
Via StockStory
Topics Economy
Exposures Supply Chain

Performance

YTD
+10.5%
+10.5%
1 Month
+31.2%
+31.2%
3 Month
-4.2%
-4.2%
6 Month
+13.8%
+13.8%
1 Year
-33.6%
-33.6%

More News

Read More
DXC Tech Stock Slides On Sour Guidance, But Retail's Happy As Q4 Results Top Estimates
Via Stocktwits
Topics Earnings
Exposures Financial
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
From DexCom, Inc.
Via Business Wire
Earnings Scheduled For May 1, 2025
Via Benzinga
A Look Into DexCom Inc's Price Over Earnings
Via Benzinga
1 Healthcare Stock with Exciting Potential and 2 to Avoid
Via StockStory
Topics Stocks
Exposures COVID-19 Product Safety US Equities
DexCom Stock: Earnings Beat and New Market Access Drive Bull Case
Via MarketBeat
Topics Earnings
Exposures Financial Product Safety
What's Driving the Market Sentiment Around DexCom?
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Via Benzinga
Nasdaq 100 Leads Wall Street Rally As China Signals Openness To Fentanyl Talks, Easing Trade Tensions
Via Benzinga
Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday?
Via Benzinga
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Via Benzinga
2 Growth Stocks to Buy and Hold for a Decade
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
DexCom (NASDAQ:DXCM) Exceeds Q1 Expectations
Via StockStory
Exposures Product Safety
Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program
From DexCom, Inc.
Via Business Wire
Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday?
Via Benzinga
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
DexCom (DXCM) Q1 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Tariff
10 Worst Performing Large-Caps Last 12 Months
Via Talk Markets
Topics Stocks / Equities
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U
From DexCom, Inc.
Via Business Wire
2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar
Via StockStory
Exposures Product Safety
3 New ETFs Finding Early Traction With Investors
Via MarketBeat
Topics ETFs
10 Worst Performing Large-Caps Last 12 Months
Via Talk Markets
Topics Stocks / Equities
Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
From Johnson Fistel, PLLP
Via Business Wire

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 86.76
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 05/19/25 03:46 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 34.02B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 34B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.